Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients

被引：0

作者：

Zaazouee, Mohamed Sayed ^{[1
]}

Elsnhory, Ahmed ^{[2
]}

Ebrahim, Rokaya Y. ^{[3
]}

Al-araj, Ghaida'a ^{[4
]}

Saad, Ahmed ^{[5
]}

Zaki, Ibram ^{[6
]}

Ali, Mustafa Hussein ^{[7
]}

Fawy, Omar Khaled Fahmy ^{[8
]}

Ahmed, Hadi F. ^{[9
]}

Elshennawy, Mohamed ^{[1
]}

Eleyan, Mohammed ^{[10
]}

Alahmad, Ziad ^{[11
]}

Hamra, Reem I. Abo ^{[12
]}

AbuEl-Enien, Hazem ^{[13
]}

Elromely, Rasha Abdo ^{[14
]}

Elshanbary, Alaa Ahmed ^{[14
]}

机构：

[1] Al Azhar Univ, Fac Med, Assiut, Egypt

[2] Al Azhar Univ, Fac Med, Cairo, Egypt

[3] Alexandria Univ, Dept Biotechnol, Fac Sci, Alexandria, Egypt

[4] Al Balqa Appl Univ, Fac Med, Salt, Jordan

[5] Menoufia Univ, Fac Med, Menoufia, Egypt

[6] Beni Suef Univ, Fac Med, Bani Suwayf, Egypt

[7] Al Taff Univ Coll, Dept Anesthesia Tech & Intens care, Karbala, Iraq

[8] Helwan Univ, Fac Med, Helwan, Egypt

[9] Red Sea Univ, Fac Med & Hlth Sci, Port Sudan, Sudan

[10] Al Aqsa Univ, Dept Lab Med Sci, Gaza, Palestine

[11] Univ Aleppo, Fac Med, Aleppo, Syria

[12] Al Quds Univ, Fac Med, Gaza, Palestine

[13] Pharos Univ, Fac Pharm & Drug Mfg, Alexandria, Egypt

[14] Alexandria Univ, Fac Med, Alexandria, Egypt

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203515

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P10-12.003

引用

页数：4

共 50 条

[1] Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine
Yang, Chun-Pai
Lee, Chia-Fang
Dell'Agnello, Grazia
Hundemer, Hans-Peter
Lipsius, Sarah
Wang, Shuu-Jiun
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1653 - 1666
[2] Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials
Zaazouee, Mohamed Sayed
Ebrahim, Rokaya Y.
Al-araj, Ghaida'a
Zaki, Ibram
Saad, Ahmed
Farhat, Abdullah Mohamed
Ali, Mustafa Hussein
Elshennawy, Mohamed
Fawy, Omar Khaled Fahmy
Ahmed, Hadi F.
Alahmad, Ziad
Nada, Eman Ayman
Abo-Hamra, Reem I.
Elsnhory, Ahmed Bostamy
Eleyan, Mohammed
AbuEl-Enien, Hazem
Elromely, Rasha Abdo
AbdelQadir, Yossef Hassan
Shah, Jaffer
Elshanbary, Alaa Ahmed
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
[3] Galcanezumab Safety/tolerability Profile Does Not Differ in Patients with Episodic or Chronic Migraine
Stauffer, V
Wang, S.
Day, K.
Saper, J. R.
HEADACHE, 2019, 59 : 45 - 46
[4] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
Diener, Hans Christoph
McAllister, Peter
Jurgens, Tim P.
Kessler, Yoel
Ning, Xiaoping
Cohen, Joshua M.
Campos, Verena Ramirez
Barash, Steve
Silberstein, Stephen D.
CEPHALALGIA, 2022, 42 (08) : 769 - 780
[5] Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
Nahas, Stephanie J.
Kessler, Yoel
Ning, Xiaoping
Cohen, Joshua M.
Campos, Verena Ramirez
Yang, Ronghua
Silberstein, Stephen D.
NEUROLOGY, 2020, 94 (15)
[6] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
Vargas, Bert B.
Ning, Xiaoping
Kessler, Yoel
Cohen, Joshua M.
Campos, Verena Ramirez
Yang, Ronghua
McAllister, Peter
NEUROLOGY, 2020, 94 (15)
[7] Safety and Tolerability of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
McAllister, Peter
Ning, Xiaoping
Kessler, Yoel
Cohen, Joshua M.
Campos, Verena Ramirez
Yang, Ronghua
ANNALS OF NEUROLOGY, 2020, 88 : S158 - S159
[8] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Shigekazu Kitamura
Takao Takeshima
Daishi Yui
Gabriel Paiva da Silva Lima
Reija Koukakis
Cheng Peng
Ryuji Yoshida
Yotaro Numachi
Miki Hasebe
Neurology and Therapy, 2023, 12 (6) : 1993 - 2006
[9] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Kitamura, Shigekazu
Takeshima, Takao
Yui, Daishi
Lima, Gabriel Paiva da Silva
Koukakis, Reija
Peng, Cheng
Yoshida, Ryuji
Numachi, Yotaro
Hasebe, Miki
NEUROLOGY AND THERAPY, 2023, 12 (06) : 1993 - 2006
[10] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
Pozo-Rosich, Patricia
Samaan, Karen H.
Schwedt, Todd J.
Nicholson, Robert A.
Rettiganti, Mallikarjuna
Pearlman, Eric M.
ADVANCES IN THERAPY, 2021, 38 (06) : 3154 - 3165

← 1 2 3 4 5 →